Sign In
Buy ASMB
$24.57
+0.0800 (+0.327%)
At Close: Jun 03, 2026
NVIDIA To $140? Plus This Analyst Cuts PT On Assembly Biosciences By 82%
02:10pm, Monday, 24'th Oct 2022 Benzinga
Truist Securities cut the price target on Assembly Biosciences, Inc. (NASDAQ: ASMB) from $11 to $2. Assembly Biosciences shares gained 2.6% to trade at $1.58 on Monday.
Mizuho cut the price target f
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
02:08pm, Monday, 24'th Oct 2022 Benzinga
Upgrades
Guggenheim upgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Sell to Neutral. Teladoc Health earned $0.44 in the second quarter, compared to $0.86 in the year-ago quarter.
Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting®
08:00am, Monday, 24'th Oct 2022
Four poster presentations, including two late breaking, highlight breadth and promise of virology portfolio
Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor
08:05pm, Wednesday, 05'th Oct 2022 GlobeNewswire Inc.
Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of the board Dr. McHutchison will continue to provide strategic counsel as
Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights
08:05pm, Tuesday, 09'th Aug 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics t
Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why
04:00pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Assembly Biosciences (ASMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for August 4th
02:00pm, Thursday, 04'th Aug 2022 Zacks Investment Research
PI, INST and ASMB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 4, 2022.
Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why
01:32pm, Thursday, 04'th Aug 2022
Assembly Biosciences (ASMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for August 4th
10:27am, Thursday, 04'th Aug 2022 Zacks Investment Research
ARI, CB, PI, ASMB and URI have been added to the Zacks Rank #1 (Strong Buy) List on August 4, 2022.
New Strong Buy Stocks for August 4th
07:32am, Thursday, 04'th Aug 2022
ARI, CB, PI, ASMB and URI have been added to the Zacks Rank #1 (Strong Buy) List on August 4, 2022.
Assembly Biosciences Announces Program Reprioritization and Organizational Update
08:05pm, Wednesday, 20'th Jul 2022 GlobeNewswire Inc.
- Discontinues clinical development of vebicorvir, Assembly Bio’s first-generation core inhibitor, based on interim efficacy data from ongoing combination clinical studies
Assembly Biosciences Presents New Data Highlighting Clinical Progress of Core Inhibitor Programs at EASL’s International Liver Congress™ 2022
12:00pm, Wednesday, 22'nd Jun 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics
7 Penny Stocks That Could Triple in 2022
07:00am, Wednesday, 22'nd Jun 2022
Some stocks currently trading in penny stock territory have unique advantages that makes it worthwhile to overlook the inherent risk involved in investing in these stocks. The post 7 Penny Stocks That
Assembly Biosciences to Introduce New Small Molecule Liver-Focused Interferon-α Receptor Agonist Research Program in Webcast on July 26, 2022
12:00pm, Tuesday, 21'st Jun 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics t
SOUTH SAN FRANCISCO, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics tar
